Alterity Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,402
Closed -$220K 79
2023
Q1
$220K Sell
5,402
-72
-1% -$3.11K 0.32% 71
2022
Q4
$280K Buy
5,474
+243
+5% +$11.7K 0.45% 54
2022
Q3
$229K Sell
5,231
-748
-13% -$36.3K 0.37% 67
2022
Q2
$313K Buy
+5,979
New +$305K 0.47% 57
2021
Q4
$327K Buy
+5,531
New +$274K 0.35% 72
2021
Q1
$295K Buy
+5,698
New +$202K 0.36% 64

Other funds holding PFE

Alterity Financial Group's PFE Position: Q2 2023 in Review

Alterity Financial Group sold out of Pfizer (PFE) in Q2 2023, closing a stake of 5,402 shares — an estimated $220K sold.

Alterity Financial Group first reported a position in PFE in Q1 2021 and held it in 6 quarters. The position peaked at $327K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Alterity Financial Group reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • Alterity Financial Group sold 5,402 Pfizer shares in Q2 2023, an estimated $220K.
  • Alterity Financial Group first reported a position in Pfizer in Q1 2021 and held it in 6 quarters.
  • Alterity Financial Group's Pfizer position peaked at $327K in Q4 2021.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Alterity Financial Group's 13F filing for Q2 2023, filed 18 Jul 2023.